Yet another study has once again affirmed that the regulation of marijuana for medical or recreational purposes is not associated with increases in problematic cannabis use by young people. “In the United States, compared to 2002, even after adjusting for covariates, cannabis use decreased among youth during 2005-2014, and cannabis use disorder declined among youth cannabis users during 2013-2014,” authors concluded.
Alcohol consumption is associated with negative changes in gray matter volume and in white matter integrity, while cannabis use is not, according to data published online ahead of print in the journal Addiction.
The US Drug Enforcement Administration has publicly reiterated its position that cannabidiol, a non-psychotropic cannabinoid, is properly categorized under federal law as a schedule I controlled substance -- meaning that, by definition, it possesses "a high potential for abuse," "no currently accepted medical use in treatment in the United States," and lacks "accepted safety ... under medical supervision."
NORML’s 2017 Conference at the Capitol Hilton in Washington, DC and Congressional Lobby Day at the United States Capitol is scheduled for September 10th-12th. Hundreds of marijuana consumers, activists, patients and business owners are expected to attend a day-long training and informational conference on Monday and re-convene on The Hill Tuesday to personally lobby their elected members of the House of Representatives and Senate.